- Omega Healthcare reported a total revenue of $282.5 million for the second quarter, reflecting a 12% increase compared to the same period last year.
- The reported total revenue was slightly below the estimated figure of $284.8 million.
- Adjusted Funds from Operations (AFFO) increased by 26% year-over-year to $232.2 million.
- The dividend per share remained steady at 67 cents, meeting both last year’s level and this year’s estimate.
- Analyst recommendations for Omega Healthcare include 7 buy ratings and 9 hold ratings, with no sell ratings issued.
A look at Omega Healthcare Investors Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 5 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Omega Healthcare Investors, Inc., a real estate investment trust (REIT) investing in the long-term care industry in the United States, shows a promising long-term outlook based on its Smartkarma Smart Scores. With a high Dividend score of 5, the company indicates strong potential for providing consistent and attractive dividends to investors. Additionally, its Momentum score of 4 suggests a positive trend in the company’s performance that may continue in the future. While Value, Growth, and Resilience scores stand at 3 each, indicating solid but not exceptional performance in these areas, the overall outlook for Omega Healthcare Investors appears to be favorable.
In conclusion, Omega Healthcare Investors, Inc. seems to be a reliable option for investors seeking a combination of steady dividends and potential growth. With its focus on the healthcare real estate sector and a track record of resilience, the company presents a stable investment opportunity. The Smartkarma Smart Scores, particularly highlighting strong Dividend and Momentum factors, support the notion that Omega Healthcare Investors holds a promising long-term outlook within the REIT industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
